K-Basket, Avelumab, Biomarker-driven, Advanced Solid Tumor

NCT03491345 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

PD-L1 Positive Mutation Tumor
EBV Positive Mutation Tumor
MSI-H Mutation Tumor
POLE/POLD1 Mutation Tumor

Interventions

DRUG: Avelumab

Sponsor

Yonsei University

Collaborators

[object Object]